Sugi Predict

Sugi Predict / Compounds / Phenamino Methyl Acetic Acid

Phenamino Methyl Acetic Acid

Phenamino Methyl Acetic Acid

SCHEMBL433918

O=C(O)CCNc1ccccc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.59
▸ ALDH1A1 P00352 4/20 0.58
▸ HSD17B10 Q99714 3/20 0.58
▸ HPGD P15428 2/20 0.58
▸ FFAR1 O14842 3/20 0.56
▸ MAPT P10636 3/20 0.56
▸ KMT2A Q03164 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ NSD2 O96028 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ L3MBTL1 Q9Y468 3/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ AKR1C3 P42330 1/20 0.51
▸ AKR1C2 P52895 1/20 0.51
▸ AKR1C1 Q04828 1/20 0.51
▸ FFAR4 Q5NUL3 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ CASP1 P29466 1/20 0.50
▸ HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10491012 0.92 POLB (0.57) POLBALDH1A1HSD17B10HPGDFFAR1
Phenamino Methyl Acetic Acid SCHEMBL28795445 0.92 ALDH1A1 (0.56) POLBALDH1A1HSD17B10HPGDFFAR1
SCHEMBL7047748 0.88 FFAR1 (0.61) POLBALDH1A1HSD17B10HPGDFFAR1
SCHEMBL2177141 0.87 ALDH1A1 (0.64) POLBALDH1A1HPGDFFAR1MAPT
Phenamino Methyl Acetic Acid SCHEMBL9449485 0.86 KMT2A (0.50) POLBALDH1A1HSD17B10HPGDFFAR1
SCHEMBL27591545 0.85 ALDH1A1 (0.61) POLBALDH1A1HPGDFFAR1MAPT
SCHEMBL27609848 0.85 ALDH1A1 (0.61) POLBALDH1A1HPGDFFAR1MAPT
SCHEMBL6130488 0.85 MAPT (0.61) ALDH1A1FFAR1MAPTKMT2AMEN1
SCHEMBL8432625 0.85 FFAR1 (0.58) POLBALDH1A1HSD17B10HPGDFFAR1
SCHEMBL10422269 0.85 POLB (0.63) POLBALDH1A1HSD17B10HPGDFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250000832-A1 ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE THERMOLIFE INT LLC (US) 2025-01-02 — — US claimed
EP-4304389-A1 ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE Thermolife International, LLC (US) 2024-01-17 — — EP claimed
CN-116940248-A Enhanced nitrate, elemental metal and amino acid compositions and methods of use 赛默生命国际公司 2023-10-24 — — CN claimed
US-20220288113-A1 ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE THERMOLIFE INTERNATIONAL, LLC 2022-09-15 — — US claimed
WO-2022192743-A1 ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE THERMOLIFE INTERNATIONAL, LLC (US) 2022-09-15 — — WO claimed
CN-113047030-A Medical cotton gauze 杭州鹿扬科技有限公司 2021-06-29 — — CN claimed
CN-111621974-A Method for producing biodegradable cold-moist bandage and use thereof 杭州鹿扬科技有限公司 2020-09-04 — — CN claimed
US-10736916-B1 Methods of improving athletic performance with inorganic nitrate compositions THERMOLIFE INTERNATIONAL, LLC (US) 2020-08-11 — — US claimed
CN-109503478-B 2, 3-dihydro-1H-quinoline-4-ketone thiosemicarbazone derivative and preparation method and application thereof 岭南师范学院 2020-04-24 — — CN claimed
WO-2011089183-A2 ANTICOAGULANT ANTIDOTES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 — — WO claimed
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents JAPAN TOBACCO INC. (JP) 2007-02-08 — — US claimed
EP-0966454-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES, THEIR PRODUCTION AND USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2003-05-07 — — EP claimed
US-RE34937-E Adhesive bonding of acrylic resins, especially in dentistry DEN-MAT CORPORATION (US) 1995-05-16 — — US claimed
EP-0377072-B1 Adhesive bonding of acrylic resins, especially in dentistry DEN MAT CORP (US) 1994-02-02 — — EP claimed
EP-0476760-A2 4-substituted isoxazole herbicides EASTMAN KODAK COMPANY (US) 1992-03-25 — — EP claimed
US-4964911-A Adhesive bonding of acrylic resins, especially in dentistry DEN-MAT CORPORATION (US) 1990-10-23 — — US claimed
EP-0140748-B1 PROCESS FOR THE PREPARATION OF 4-QUINOLINONES RHONE-POULENC SANTE (FR) 1987-01-14 — — EP claimed
US-4593101-A Process for the preparation of 4-quinolinones RHONE-POULENC SANTE (FR) 1986-06-03 — — US claimed
EP-0056763-B1 PROCESS FOR THE PREPARATION OF 4-QUINOLINONES RHONE-POULENC SANTE (FR) 1984-07-04 — — EP claimed
US-4412075-A Process for the preparation of quinolin-4-ones RHONE-POULENC SANTE (FR) 1983-10-25 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents PYGL, GYS2, AGL POLB 3038/4885ALDH1A1 1278/4885HSD17B10 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.